Agent Capital is a Cambridge, MA-based biotech venture capital firm focused on investing in novel therapeutics that address unmet patient needs. The firm focuses its investments on new products and technologies for oncology, immunology, neurology, and rare disease indications. The firm makes direct investments across all stages of development alighted with its two-pronged approach, which includes early-stage investments in transformative technologies (typically pre-clinical or Phase 1 and later stage investments in companies approaching major inflection points (typically Phase 2/3, pre-IPO or already public).
Venture Capital
1 funds found in our dataset.
Built for investment teams that need to move faster.
Intelligently process data room financials, generate auditable analyses, and export IC-ready deliverables.